Overall, these data support the involvement of 5-HT in the regulation of energy expenditure 234,235 and suggest that targeting peripheral 5-HT may constitute a therapeutic strategy for the treatment of obesity and associated metabolic dysfunctions. Here, HTR5A is linked to obesity due to melanocortin 4 receptor deficiency.